Emergent BioSolutions clinical trials we track

Check company identity source

Phase 3 4 trials

Phase 2 / 3 1 trial

TrialDrugs studiedStatusPrimary completion
HuMax-CD4 in Non-Cutaneous T-Cell LymphomaNCT00877656HuMax-CD4Completed2006-01Actual

Phase 2 8 trials

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters